FDA OKs new adhesive to treat burn victims

Mar 20, 2008

The U.S. Food and Drug Administration approved a medical adhesive -- a fibrin sealant called Artiss -- for use in attaching skin grafts to burn patients.

Fibrin sealants are tissue adhesives that contain the proteins fibrinogen and thrombin, which are essential in the clotting of blood. The FDA said Artiss differs from other fibrin sealants in that it contains a lower concentration of thrombin, allowing surgeons more time to position skin grafts over burns before the graft begins to adhere to the skin.

Artiss also contains aprotinin, a synthetic protein that delays the break down of blood clots.

"The approval of Artiss can help surgeons using a fibrin sealant to fine tune graft placement on burn sites," said Dr. Jesse Goodman director of the FDA's Center for Biologics Evaluation and Research. "The approval also provides an additional choice for health care professionals in providing burn treatment."

The fibrinogen and thrombin proteins in Artiss are derived from human plasma, collected from FDA-licensed plasma centers. Both proteins undergo purification and virus inactivation treatments to reduce the risk of blood-transmissible infections, the agency said.

Artiss is manufactured by the Baxter Healthcare Corp. of Deerfield, Ill.

Copyright 2008 by United Press International

Explore further: Bristol-Myers: FDA blocks hepatitis C drug for now

add to favorites email to friend print save as pdf

Related Stories

Form Devices team designs Point as a house sitter

14 hours ago

A Scandinavian team "with an international outlook" and good eye for electronics, software and design aims to reach success with what they characterize as "a softer take" on home security. Their device is ...

Man pleads guilty in New York cybercrime case

17 hours ago

A California man has pleaded guilty in New York City for his role marketing malware that federal authorities say infected more than a half-million computers worldwide.

Battery support for renewable sources announced by Aquion

Nov 16, 2014

Aquion evokes two words, aqueous and ion—fittingly, since the Pennsylvania-based company, Aquion Energy, is known for Aqueous Hybrid Ion (AHI) battery systems. They are designed for long-duration cycling ...

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

7 hours ago

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.